P
PepGen
2 followers
Driven by its proprietary Enhanced Delivery Oligonucleotide (EDO) platform, PepGen is creating a pipeline of disease-modifying therapeutics with the potential to safely and effectively target the root cause of serious genetic diseases, with an initial focus on neuromuscular diseases.
Org chart
James McArthur
President & CEO
James McArthur
Collapse
Jaya Goyal
EVP, Research & Preclinical Development
Niels Svenstrup
SVP, Chemistry, Manufacturing & Controls
Michelle Mellion
SVP & Head, Clinical Development
Debra Sawyer
VP, Quality Assurance
Hayley Parker
VP, Global Regulatory Affairs
Emiko Bryant
Chief Of Staff
Christine W.
Human Resources Manager
Board & advisors
Michael Gait
Founder
Laurie Keating
Chair, Board of Directors
Chris Ashton
Non-Executive Director
Josh Resnick
Non-Executive Director
Heidi Henson
Non-Executive Director
Habib Joseph Dable
Non-Executive Director
John Watts
Scientific Advisor
Beth McNally
Scientific Advisor
Art Krieg
Scientific Advisor
Brenda Wong
Scientific Advisor
Charles Thornton
Scientific Advisor
John W. Day
Scientific Advisor
Matthew Wood
Scientific Advisor
Offices
Similar companies
Tango Therapeutics
2 followers
Lycia Therapeutics
1 follower
Ultima Genomics
3 followers
Cellares
2 followers
Thermo Fisher Scientific
184 followers
Genentech
164 followers
Illumina
73 followers
Verily Life Sciences
39 followers
BioMarin Pharmaceutical
38 followers
Ionis Pharmaceuticals
29 followers
GRAIL
27 followers
Explore companies